Sherrington Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 75.50 Cr
- Satisfied Charges ₹ 1.62 Cr
- Revenue Growth 18.29%
- Profit Growth 25.31%
- Ebitda -12.04%
- Net Worth 18.29%
- Total Assets 26.30%
About Sherrington Pharmaceuticals
Sherrington Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 October 2002 and has a history of 22 years and three months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹75.50 Cr. The company has closed loans amounting to ₹1.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manogna Yeluri and Yeluri Prasad serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24231TG2002PTC039741
- Company No.
039741
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sherrington Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manogna Yeluri  | Managing Director | 19-Aug-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yeluri Prasad | Director | 09-Oct-2002 | Current |
Financial Performance of Sherrington Pharmaceuticals.
Sherrington Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.29% increase. The company also saw a substantial improvement in profitability, with a 25.31% increase in profit. The company's net worth Soared by an impressive increase of 18.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sherrington Pharmaceuticals?
In 2023, Sherrington Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yeluri Formulations Private LimitedManogna Yeluri and Yeluri Prasad are mutual person
Charges (Loans)
₹754.98 M
₹16.24 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 44.21 Cr
- Others : 20.74 Cr
- Ing Vysya Bank Limited : 10.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2022 | Hdfc Bank Limited | ₹2.11 M | Open |
| 03 Mar 2021 | Hdfc Bank Limited | ₹44.00 Cr | Open |
| 21 Sep 2017 | Others | ₹20.74 Cr | Open |
| 23 Aug 2011 | Ing Vysya Bank Limited | ₹8.55 Cr | Open |
| 28 Feb 2011 | Ing Vysya Bank Limited | ₹2.00 Cr | Open |
How Many Employees Work at Sherrington Pharmaceuticals?
Unlock and access historical data on people associated with Sherrington Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sherrington Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sherrington Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
